Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Englelyna, Frisca"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    ANALISIS RISIKO DAN PENGEMBALIAN INVESTASI BERDASARKAN MODEL PRAKTIS MODAL MODAL PERUSAHAAN PADA SUB SEKTOR FARMASI DI BURSA EFEK INDONESIA
    (Seminar Nasional Akuntansi dan Bisnis (SNAB), Fakultas Ekonomi Universitas Widyatama, 2017-07-20) Hutabarat, Francis M.; Englelyna, Frisca
    Investment is indeed essential for the economic development of a country. Every country are in need and aspire to gain investment in every sub sector of industry given. In analyzing and measuring the kind of investment that are good and risky, there are many ways that can be done to measure it. This study aimed to measure and analyze Pharmaceutical sub sector of the Indonesian Stock Exchange using Capital Asset Pricing Model. The sample used is active companies in stock transaction, such as: DVLA, INAF, PYFA, KAEF, SCPI, KLBF, SIDO, MERK, SQBI, and TSPC listed in Pharmaceutical sub sectors. Based on the results of the study, it can conclude that after analyzing the Pharmaceutical sub sector of the Indonesian Stock Exchange using Capital Asset Pricing Model, and the results shows that the Beta are below 1 and shows defensive type of stocks and has overvalued return compared to their expected return for all companies based on the period observed from December 2013 to July 2016.

PTI copyright © 2002-2026

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback